Core Laboratories N.V.
CLB | NYSE
$8.93
-$0.72 (-7.46%)
At close: Nov 5, 2026, 4:00 PM ET
$8.93
$0.00 (0.00%)
After-hours:
Nov 5, 2026, 4:01 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 22.7M | 19.16M | 15.12M | 15.43M | 17.7M | 13.81M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 4.43M | 5.08M | 4.84M | 4.45M | 4.16M | 4.09M |
Other Long-Term Assets | 30.84M | 29.71M | 29.38M | 29.3M | 37.26M | 36.16M |
Receivables | 120.8M | 127.36M | 123.07M | 115.1M | 106.74M | 83.19M |
Inventory | 54.5M | 59.4M | 71.7M | 60.45M | 45.44M | 38.15M |
Other Current Assets | 6.94M | 10.52M | 5.09M | 5.06M | 5.11M | 15.9M |
Total Current Assets | 214.67M | 226.61M | 223.14M | 211.7M | 189.06M | 165.85M |
Property-Plant & Equipment | 153.79M | 153.55M | 153.47M | 157.41M | 172.34M | 181.68M |
Goodwill & Intangibles | 112.91M | 105.85M | 106.37M | 106.93M | 107.58M | 108.03M |
Total Long-Term Assets | 369.35M | 363.8M | 363.26M | 366.65M | 391.8M | 402.73M |
Total Assets | 584.01M | 590.41M | 586.4M | 578.35M | 580.85M | 568.58M |
Account Payables | 37.28M | 34.55M | 33.51M | 45.85M | 29.73M | 23.03M |
Deferred Revenue | 5.55M | 9.33M | 4.76M | 5.94M | 7.77M | 5.46M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 20.95M | 8.16M | 13.59M | 13.18M | 13.61M | 14.96M |
Total Current Liabilities | 106.02M | 97.59M | 88.1M | 103.14M | 90.78M | 89.75M |
Long-Term Debt | 110.26M | 126.11M | 163.13M | 172.39M | 188.64M | 259.43M |
Other Long-Term Liabilities | 15.85M | 51.85M | 20.04M | 20.88M | 27.71M | 27.99M |
Total Long-Term Liabilities | 205.79M | 235.08M | 268.49M | 286.27M | 329.07M | 403.26M |
Total Liabilities | 311.8M | 332.67M | 356.59M | 389.4M | 419.85M | 493.01M |
Total Debt | 164.02M | 180.14M | 215.39M | 222.39M | 250.26M | 326.98M |
Book Value | 272.21M | 257.74M | 229.81M | 188.95M | 161M | 75.57M |
Book Value Per Share | 5.85 | 5.40 | 4.84 | 4.04 | 3.45 | 1.68 |
Common Stock | 470K | 470K | 469K | 1.19M | 1.19M | 1.15M |
Retained Earnings | 172.66M | 150.28M | 120.76M | 85.95M | 68.35M | 50.46M |
Comprehensive Income | -5.81M | -5.77M | -4.97M | -3.78M | -10.13M | -7.2M |
Shareholders Equity | 265.99M | 251.99M | 224.82M | 184.26M | 156.45M | 71.51M |
Total Investments | 4.43M | 5.08M | 4.84M | 4.45M | 4.16M | 4.09M |
Add to Watchlist
Select watchlists to add or remove CLB